ライフサイエンスコーパス: promotor

1 s then protonated/metalated by the catalyst (promotor).

2 i BL21 with the pel gene under the strong T7 promotor.

3 the major histocompatibility complex I gene promotor.

4 t located at position -265/-239 in the EGF-R promotor.

5 full-length HLA-DR4 cDNA driven by a CMV IE promotor.

6 rt of an operon but transcribed from its own promotor.

7 murine leukemia virus long terminal repeat) promotor.

8 cal E-box element located within the alphaBC promotor.

9 e dilithium salt of (S)-BINOL was added as a promotor.

10 s driven by the muscle creatine kinase (MCK) promotor.

11 ssociated oncogene 1 and 2, bind to the PLK2 promotor.

12 d by the glutamic acid decarboxylase (GAD)67 promotor.

13 expression of luciferase driven by the ATGL promotor.

14 ression was achieved with a myocyte-specific promotor.

15 aldosterone responsiveness to a heterologous promotor.

16 n/Tcf-4-responsive elements in the PPARdelta promotor.

17 ase pair (bp)/-349-bp region of the proximal promotor.

18 and either the red or the green pigment gene promotor.

19 ed gene transcription from a LEF-1-dependent promotor.

20 m caspases from tumor suppressors into tumor promotors.

21 gulates its interaction with endogenous ATGL promotors.

22 ermis after topical application of the tumor promotor 12-O-tetradecanoyl-phorbol-13-acetate (TPA) was

23 With NIS/TfOH as the promotor, 2,6-di-tert-butyl-4-methylpyridine as the base

24 , Th1 cells from T-bet-/- mice manifest IFNG promotor accessibility as detected by histone acetylatio

25 Gl also produced a marked inhibition of IL-2 promotor activity as determined by transient transfectio

26 state-13-acetate plus ionomycin-induced IL-2 promotor activity by 18%, 28%, 39%, and 54%, respectivel

27 and mutant p53Ala143 enhanced the EGF-R core promotor activity in cells that were either p53-deficien

28 Ca2+-sensitive involucrin AP-1 promotor activity was increased, both in HHD keratinocyt

29 TLR4 promotor activity, as well as AP-1 activation and the ef

30 2B1 gene driven by the cytomegalovirus (CMV) promotor ad.CMV-2B1 was constructed and used to infect a

31 Under the control of the APETALA3 promotor, AGAMOUS is misexpressed in the second whorl of

32 uced transcriptional activity of the HIV LTR promotor, an effect that required both NFkappaB and SP1

33 Sequencing detected 13 polymorphisms (three promotor and 10 coding) among 288 AR patients.

34 trong [cytomegalovirus (CMV) immediate early promotor and enhancer] or an intermediate strength (Molo

35 of the serum-inducible element in the c-fos promotor and GAS which resembles the INF-gamma activatio

36 -1 promotor, the virus established an active promotor and this contributed to the acute infection of

37 genomic structure, position of the proximal promotor, and intron-exon border sequences of the 30-exo

38 ns expressing GFP under control of the dmrt3 promotor are analyzed.

39 specific DNA target site for CRP and the lac promotor are located within thermalite II.

40 combination of chromatin immunoprecipitation promotor arrays (ChIP-chip) and gene expression profilin

41 control of a glial fibrillary acidic protein promotor (AstroCD24TG mice).

42 ssay showed increased Sp1 binding to the Arf promotor at 24 and 48 hours after Tgfbeta treatment, at

43 that two adjacent mutations in the HBV core promotor (C to T at nucleotide 1768 and T to A at nucleo

44 ults in the activation of transcription from promotors containing the cAMP response element (CRE).

45 The -167/-105 segment of the EGF-R promotor contains one perfect and several imperfect cons

46 LB/neuT mice, expressing rat neuT under mmtv promotor control, spontaneously developed tumorous lesio

47 gonucleotide treatment also enhanced the p53 promotor-directed transcription in vivo along with the i

48 ist treatment induced E2F-1 binding to FoxC2 promotor directly and improved FoxC2 transcription.

49 Mice with smooth muscle protein-22alpha promotor-driven deficiency of the disintegrin and metall

50 MC4-R promotor-driven GFP expression was found in PVH cells pr

51 revin, under the control of the pan-neuronal promotor elav to label the neuropil in the live animal.

52 ription factor that binds the B-box internal promotor element of tRNA genes and the complex of TFIIIA

53 has located a number of potential A-form DNA promotor elements in the Xenopus genome, five of these p

54 The interactions between enhancers and promotor elements that control gene expression are gener

55 The promotor for this gene and the alternatively spliced exo

56 The target-sites on the transferrin receptor promotor for YY1 lie in close proximity to those of the

57 Independent of carriage and DEFB promotor haplotype, a 1-unit increase in the IFN-gamma t

58 and the analysis of its function at the Dbh promotor implicated Hand2 in the control of noradrenergi

59 A was created through insertion of the Pnpt-promotor in front of the NRPS gene.

60 of acute-phase responsive and cytokine gene promotors in response to inflammation.

61 cer mechanisms are distinct in UV- and tumor promotor-induced cancer models and indicates that chemop

62 rotein (GP) under the control of the insulin promotor (Ins2) were stained for neuropeptide Y before,

63 nd luciferase constructs driven by IGF-II P3 promotors into multiple cell lines.

64 PEAT1 or LPEAT2 under the control of the 35S promotor led to morphological changes opposite to what w

65 luated by transient transfection of the hCAR promotor-luciferase reporter constructs, followed by pro

66 ne THP-1 were transfected with an NF-kappa B promotor/luciferase construct and activated.

67 egions were identified, wherein the proximal promotor mediated PDGF-BB inhibition of transcription.

68 ival, as well as an association between MGMT promotor-methylated tumors and PTEN positivity shown by

69 s a strong positive correlation between MGMT promotor methylation and survival, as well as an associa

70 ch overexpresses Cyfip1 under the endogenous promotor, observing an increase in the proportion of mat

71 tial tumour suppressor genes at 9p21 and the promotor of CDKN2A has been unable to explain genetic pr

72 ion assay demonstrated that MYC binds to the promotor of FAM83H and that MYC promotes the transcripti

73 B-type ARRs bind to the promotors of HEMA1 and LHCB6 genes, indicating that cyto

74 yeloid cells (by using the lysozyme M [LysM] promotor) or specifically in DCs (by using the Cd11c pro

75 utation, but no mutations are present in the promotor, or protein coding sequences or splice sites of

76 AMOUS gene under the control of the APETALA3 promotor (pAP3::AG).

77 promotor Pspc; (ii) the beta-lactamase gene promotor Pblaof plasmid pBR322; (iii) the PLpromoter of

78 ort, long) at the serotonin transporter gene promotor polymorphism (5-HTTLPR) locus of SLC6A4 now exi

79 The glial fibrillary acidic protein (GFAP) promotor possesses an AP-1 binding site, the target for

80 Consistent with this, compact promotor-proximal sequences are sufficient for string fu

81 include (i) the spc ribosomal protein operon promotor Pspc; (ii) the beta-lactamase gene promotor Pbl

82 A 160-bp fragment encompassing the promotor region and the putative iron boxes of the fbpA

83 t the two adjacent mutations in the HBV core promotor region are responsible for the enhanced replica

84 as with DEXI expression, interacted with the promotor region of DEXI but not with candidate DNA fragm

85 ur an integration of a Doc retroposon in the promotor region of RpS3a.

86 Recently, in the promotor region of the HO-2 gene a consensus sequence of

87 I footprint analysis in the upstream 260 bp promotor region of the human DBH gene, of which two site

88 To analyze the promotor region of the human macrophage-stimulating prot

89 omolog (PTEN), and methylation status of the promotor region of the MGMT gene were analyzed from tumo

90 We show here that the promotor region of the rate-limiting lipolytic enzyme, a

91 we report a detailed characterization of the promotor region, the 5'- and 3'-untranslated region (UTR

92 e addition of the first operator site in the promotor region.

93 ion has therefore focused on studying G4s in promotor regions of disease-related genes.

94 hat searches for occurrences of TFBSs in the promotor regions of up/down regulated or random genes.

95 cription initiation sites and their flanking promotor regions were identified, wherein the proximal p

96 sensus MYCN binding E-box sequences in their promotor regions, suggesting they represent direct targe

97 all of which contain CRE sites within their promotor regions.

98 d to IFN-stimulating response element (ISRE) promotor regulation.

99 under control of a tetracycline-repressible promotor, removal of doxycycline resulted in detectable

100 In this study, promotor-reporter assays in yeast and Drosophila S2 cell

101 ontrol of the endogenous Tas1r1 and Tas2r131 promotor, respectively.

102 uences of the sequential 5' deletions of the promotor revealed that multiple positive and negative re

103 We have generated transgenic rat insulin promotor (RIP)-CXCL10 mice expressing CXCL10 in the beta

104 e, cytosine deaminase expressed from the CMV promotor seems to be the most promising toxin gene for h

105 immunoglobulin heavy chain germline epsilon promotor sequence (Iepsilon) in an electrophoretic mobil

106 n to be modulated by various factors such as promotor, solvent, anomeric ratio of donor, nature of ac

107 specific DNA motifs in the 1000 bp proximal promotor, some of which associate with known transcripti

108 by chromatin immunoprecipitation followed by promotor-specific quantitative polymerase chain reaction

109 ted O(6)-methylguanine-DNA methyltransferase promotor, standard temozolomide (TMZ) has, at best, limi

110 t with another CARD protein, interferon-beta promotor stimulator protein-1 (IPS-1, also known as MAVS

111 to be largely responsible for the increased promotor strength of this particular allelic form of the

112 Through promotor-swap experiments, the expression profile of eac

113 These results suggest that WAP promotor-targeted Int3 function is associated with mamma

114 is a potent antiapoptotic protein and tumor promotor that is expressed in both small cell lung cance

115 ult of hyperacetylation of histones on HIV-1 promotor, the virus established an active promotor and t

116 tion in the context of a zebrafish rhodopsin promotor to convert its specificity from rod-only expres

117 PGs in limiting regeneration, using the gfap promotor to express a CSPG-degrading enzyme chondroitina

118 osed complexes between this polymerase and a promotor to open complexes in a reaction that depends up

119 We have used the rat tyrosine hydroxylase promotor to overexpress MYCN in the neural crest of tran

120 sing POP2 controlled by its endogenous human promotor to study the immunological functions of POP2.

121 ) or specifically in DCs (by using the Cd11c promotor) to acute and chronic house dust mite (HDM)-dri

122 ld-type mouse skin in response to the tumour promotor TPA.

123 Chicken ovalbumin upstream promotor-transcription factor I (COUP-TFI), an orphan me

124 quires a catalyst (typically iron, Fe) and a promotor (typically sulfur, S), their synergistic roles

125 serotonin transporter genotype at the SLC6A4 promotor VNTR polymorphism in 30 healthy subjects who al

126 enge, but only within areas where the CYP1A1 promotor was already active.

127 ssion of h2-calponin using a cytomegalovirus promotor was independent of the stiffness of culture mat

128 Absence of nucleosomes from the LTP-promotor was not sufficient to provoke robust transcript

129 induced by activation of a doxycycline (Dox) promotor, we tested the effects of Tat on cocaine (10 mg

130 ounts of IL-10 under the control of the IL-2 promotor were infected with M. tuberculosis via the resp

131 r the control of the liver activator protein promotor with transgenic mice carrying a constitutively